The Pharmacy and Poisons Board (PPB) has slashed the period required to evaluate and register new cancer drugs from two years to three months.
Uncover the stories others won’t tell. Subscribe now for exclusive access
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted